Atara Biotherapeutics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Atara Biotherapeutics Stock Summary

Atara Biotherapeutics competes with Fate Therapeutics, Sana Biotechnology, Caribou Biosciences, Arcus Biosciences, and Heron Therapeuti. Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. The company was incorporated in 2012 and is headquartered in South San Francisco, California. Atara Biotherap operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 578 people.

Atara Biotherapeutics Key Financial Ratios

Atara Biotherapeutics Key Balance Sheet Accounts

Atara Biotherapeutics Key Income Statement Accounts

Atara Biotherapeutics Key Cash Accounts

Atara Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Atara Biotherapeutics's current stock value. Our valuation model uses many indicators to compare Atara Biotherapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Atara Biotherapeutics competition to find correlations between indicators driving Atara Biotherapeutics's intrinsic value. More Info.Atara Biotherapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Atara Biotherapeutics' Return On Equity is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Atara Biotherapeutics' earnings, one of the primary drivers of an investment's value.

Atara Biotherapeutics Systematic Risk

Today, most investors in Atara Biotherapeutics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Atara Biotherapeutics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Atara Biotherapeutics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Atara Biotherapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Atara Biotherapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Atara Biotherapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Atara Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Atara Biotherapeutics's daily price indicators and compare them against related drivers.

When running Atara Biotherapeutics' price analysis, check to measure Atara Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atara Biotherapeutics is operating at the current time. Most of Atara Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Atara Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atara Biotherapeutics' price. Additionally, you may evaluate how the addition of Atara Biotherapeutics to your portfolios can decrease your overall portfolio volatility.